Omnyx LLC, Pittsburgh, a joint venture of GE Healthcare, Waukesha, Wis, and the University of Pittsburgh Medical Center (UPMC), has announced two strategic collaborations in conjunction with the launch of the next generation of its digital pathology software, Dynamyx. With its intuitive design and enhanced tools, the software aids clinicians in performing a variety of tasks and enables pathologists to adapt to a digital workflow.
Since 2013, Omnyx has been working with Visiopharm, Broomfield, Colo, to advance cancer diagnostics through the development of clinically validated image analysis algorithms. The integration of Visiopharm’s breast panel analysis algorithms (HER2, ER, PR, Ki67) is set to provide pathologists with additional insights when evaluating certain breast tissue specimens, helping to standardize data and produce concise and consistent results.
“Over the last year, we have worked closely with Visiopharm to move from great ideas to a product set that realizes our mutual vision to enhance image analysis for breast cancer,” says Mamar Gelaye, CEO of Omnyx. “This signifies the first step in a continued commitment on the part of both companies to create value for our mutual customers.”
“Omnyx has a comprehensive workflow solution, and incorporating image analysis is essential to fulfilling the promise of digitization to pathologists,” says Michael Grunkin, CEO and founder of Visiopharm.
Further increasing user options, the Omnyx Dynamyx software now includes integration with the desktop scanner from Objective Imaging, Kansasville, Wis, providing image viewing continuity through the use of the single Omnyx viewer. In addition to being ideal for smaller workspaces and remote collaboration, the scanner facilitates new applications for digital pathology, such as consultation, education, research, and small-use cases.
Omnyx and Objective Imaging have been working together throughout the past year on the joint product release, including recently achieving a CE mark for the desktop scanner, and a commercial model in support of Omnyx’s distribution of Objective Imaging’s product.
“The integration of the Objective Imaging desktop scanner with the new Omnyx Dynamyx platform represents an important step forward in increasing the value of high-performance whole slide imaging in the market,” says Don Laferty, president of Objective Imaging. “Our collaboration expands the availability of innovative, high-quality digital pathology solutions that benefit both pathologists and their patients.”
“Objective Imaging has long-standing capabilities in scanning components, and their recent release of a fully integrated desktop scanner offers Omnyx’s customers the versatility to connect distributed networks of pathologists for consultations,” adds Gelaye. “We are excited to collaborate and make these capabilities more accessible to pathologists.”